Quantcast
Channel: Bothell RSS Feed
Browsing all 12 articles
Browse latest View live

AVI BioPharma gets FDA OK for Marburg virus drug

AVI BioPharma Inc. said it's received Food and Drug Administration approval to continue testing a single drug aimed at treatment of Marburg virus infection. Marburg virus is a severe and potentially...

View Article



OncoGenex raises $46.8M in offering; shares dip

OncoGenex Pharmaceuticals Inc. said it's raised $46.8 million in an offering of 4.165 million shares of its stock. The Bothell biotech said it priced the shares at $12 each and underwriters have 30...

View Article

Fujifilm completes $995M purchase of SonoSite

Japanese film company Fujifilm has completed its purchase of portable ultrasound maker SonoSite Inc. of Bothell for $995 million. SonoSite shares (NASDAQ: SONO) will no longer be traded on the NASDAQ...

View Article

AVI BioPharma: Longer test needed for muscular dystrophy drug

AVI BioPharma Inc. said a study of its eteplirsen drug for boys with Duchenne muscular dystrophy (DMD) "met the primary efficacy endpoint" but added a longer study will be needed. A 12-week study "did...

View Article

Seattle Genetics pares Q1 loss, stock slips

Seattle Genetics Inc. reported a first-quarter loss of $12.3 million, or a loss of 11 cents per share, which compares with a loss of $32.7 million, or a loss of 30 cents per share a year earlier. The...

View Article


Image may be NSFW.
Clik here to view.

Marina Biotech stops most day-to-day operations

Marina Biotech Inc., the Bothell company that was concentrating on developing RNA-based therapies for cancer, including bladder cancer, is shutting down most of its operations. In a press release,...

View Article

Seattle Genetics prostate cancer drug trial results 'encouraging'

Seattle Genetics Inc. said the results of a trial for its drug targeting the treatment of castration-resistant prostate cancer were "encouraging." Bothell-based Seattle Genetics (NASDAQ: SGEN) is...

View Article

Microsoft, GE complete creation of Caradigm health-care company

Microsoft Corp. and General Electric Co. said they've completed the creation of their new health-care company — Caradigm — which will be located in City Center Bellevue. The two companies announced the...

View Article


Cardiac Science names new CEO

Cardiac Science Corp., the Bothell maker of automated external difibrillators and electrocardiac devices that was bought by Opto Circuits of India for about $55 million two years ago, has named Neal...

View Article


Image may be NSFW.
Clik here to view.

AVI BioPharma changes name to Sarepta, splits stock

AVI BioPharma Inc. said it's changed its name to Sarepta Therapeutics Inc. and also enacted a one-for-six reverse stock split. The Bothell company said its shares will being trading (on a...

View Article

Image may be NSFW.
Clik here to view.

Sarepta says MD drug has 'significant' benefit; stock soars

Sarepta Therapeutics Inc., which used to be known as AVI BioPharma Inc., said a study of its eteplirsen treatment for patients with Duchenne muscular dystrophy (DMD) showed a "significant clinical...

View Article

Image may be NSFW.
Clik here to view.

Deloitte Fast 500 recognizes 21 Northwest companies

The connections we make are critical to success in business, whether they be personal or professional. For the 18th year in a row, Deloitte is recognizing Washington state’s fastest-growing technology...

View Article
Browsing all 12 articles
Browse latest View live




Latest Images